TranexaMir contains Tranexamic Acid 500 mg, an antifibrinolytic formulation used to help reduce and control excessive bleeding.

Formulation: Tranexamic Acid 500 mg
Packaging: 5 × 5 ml Ampoules

Product Description:
TranexaMir works by helping stabilize blood clots and reduce their breakdown, making it useful in the management of bleeding associated with various clinical conditions and surgical procedures. The injectable formulation is intended for administration by a qualified healthcare professional through the prescribed route and dosage.